Effectiveness and safety of joint cavity fenestration in the treatment of finger mucinous cysts
LIU Ya-jing,XU Guo-dong
Abstract:
Objective To study the effectiveness and safety of joint cavity fenestration in the treatment of finger mucinous cysts. Methods From January 2021 to January 2023, 80 cases of patients with finger mucinous cysts treated in our hospital were selected as the research subjects. According to the random number table method, the 80 patients were divided into the fenestration group and the traditional group, 40 cases each group. The fenestration group received joint cavity fenestration treatment, while the traditional group received simple cystectomy treatment. The effectiveness and safety of both groups were recorded. Results All patients successfully completed the surgery, and the postoperative incisions healed in stage I. The surgical time, the intraoperative bleeding and postoperative hospitalization time in the fenestration group were significantly less than those in the traditional group (P <0.05). The pain VAS scores of the fenestration group were significantly reduced compared to the traditional group on postoperative day 1, 7, and 14 (P <0.05). The excellent and good efficacy rate of the fenestration group after 3 months of surgery was 97.5%, while that of the traditional group was 85.0%. The fenestration group was significantly higher than the traditional group (P <0.05). The incidence of complications such as infection, bleeding, and nerve damage 3 months after surgery in the fenestration group was 2.5%, while in the traditional group it was 17.5%. The window opening group was significantly lower than the traditional group (P <0.05). All patients were followed up with an average follow-up time of (32.10±2.18) months. The recurrence rate of the fenestration group was 2.5%, while that of the traditional group was 17.5%. The window opening group was significantly lower than the traditional group (P <0.05). Conclusion Joint cavity fenestration treatment for finger mucinous cysts can reduce intraoperative bleeding, postoperative hospitalization time, promote pain relief in patients, improve the rate of excellent and good therapeutic effects, reduce the incidence of complications in patients, and also reduce the recurrence rate during follow-up.
